DeutschNewstral
Article
The Globe and Mail on 2017-12-22 11:42
Roche to buy U.S. cancer drug specialist Ignyta for $1.7-billion
Related news
Roche Bolsters Cancer Portfolio With $1.7 Billion Ignyta Dealwsj.com
Roche invests in US specialist cancer firmthelocal.ch
Dr Pepper Snapple to buy Bai Brands for $1.7 billionmetro.us- Dr Pepper Snapple to buy Bai Brands for $1.7-billionThe Globe and Mail
- Roche launches cancer immunotherapy research networkmetro.us
- IRoche to buy U.S. based GenMark Diagnostics for £1.29 billioninvezz.com
UK-based company said set to buy Keter Plastics for $1.7 billiontimesofisrael.com
Roche to buy bowel drugmaker Telavant for $7.1 billion - Mon, 23 Oct 2023 PSTsyndication.washingtonpost.com
Roche To Buy Big Data Upstart Flatiron Health For $1.9 BillionForbes- Swiss giants Roche to buy US gene therapy group Spark for $4.3 billionthelocal.ch
Could Iran Use Its $1.7 Billion Cash Jackpot To Buy North Korean Nukes?canadafreepress.com- Roche Nears Deal to Buy Spark Therapeutics for Close to $5 Billionwsj.com
Gilead to buy Kite for $11.9 billion in cancer megadeal - Mon, 28 Aug 2017 PSTThe Spokesman-Review- TBristol Myers to buy cancer specialists Mirati Therapeutics for $5.8 billionthestreet.com
Swiss pharma company Roche is buying Flatiron Health for $1.9 billionTechCrunch- Xylem to Buy Sensus for $1.7 Billionwsj.com
- Shire, Roche slug it out in billion-dollar blood drug battlemetro.us
- Roche takes over US cancer analysis firmthelocal.ch
Demand for breast cancer drugs lifts RocheThe Salt Lake Tribune
'UBS agrees to buy Credit Suisse for over $2 billion'The Times of India